Mol Cell Oncol

APOBEC3 as a driver of genetic intratumor heterogeneity.

Venkatesan S, Angelova M, Bartkova J, ..., Kanu N, Swanton C

Mol Cell Oncol 10 (1) 2014734 [2022-01-03; online 2022-01-03]

Targeting tumor vulnerabilities associated with loss of heterozygosity.

Rendo V, Stoimenov I, Sjöblom T

Mol Cell Oncol 7 (4) 1759390 [2020-05-13; online 2020-05-13]

SAMHD1 is a barrier to antimetabolite-based cancer therapies.

Rudd SG, Schaller T, Herold N

Mol Cell Oncol 4 (2) e1287554 [2017-02-03; online 2017-02-03]

Pleiotrophin is a driver of vascular abnormalization in glioblastoma.

Zhang L, Dimberg A

Mol Cell Oncol 3 (6) e1141087 [2016-02-18; online 2016-02-18]